“Because sudden cardiac arrest (SCA) is a risk on any athletic field, whether due to commotio cordis or an undiagnosed heart problem, it’s imperative to have AEDs on site at sporting events like the World Lacrosse Championships,”
“HeartSine is one of the nation’s leading suppliers of invaluable AEDs, and we appreciate its support of the FIL World Championship,”
The medical tents at the WLC will be equipped with HeartSine samaritan PAD 350P AEDs, which feature easy-to understand visual and voice prompts that guide a user through the rescue process, including CPR coaching which verbally guides the rescuer through the CPR process. The most robust AED available on the market, providing the highest level of moisture and dust ingress protection in the industry, the SAM 350P AED is ideally suited to use in a medical tent and on a sports side line.
Teams from 38 countries across the globe will compete in the 2014 Federation of International Lacrosse World Championship, which will be held July 10 through 19 in Denver, Colorado. Tickets are on sale at www.worldlacrosse2014.com/
About SCA and Commotio Cordis
Sudden cardiac arrest (SCA) is a condition in which the heart suddenly and unexpectedly stops beating, causing blood to stop flowing to the brain and other vital organs. SCA usually causes death if it's not treated within minutes. CPR alone will not restart the heart, so the American Heart Association recommends CPR combined with early defibrillation (within three to five minutes) for the best outcome.
Commotio cordis, Latin for “commotion or disturbance of the heart”, is caused by a blunt trauma to the area of the chest directly over the heart during a precise moment of the heart’s cycle, leading to sudden cardiac arrest which is only reversible with prompt defibrillation. Relatively recent data from the registry of the Minneapolis Heart Institute Foundation show that commotio cordis is the leading cause of sudden cardiac death in young athletes.
SCA claims more than seven million lives annually. It occurs abruptly and without warning, with 84 percent of SCA events occurring outside of the healthcare setting.
About HeartSine Technologies
HeartSine Technologies, a world leader in personal and public access defibrillators, advances the deployment of life-saving defibrillation therapy for the treatment of Sudden Cardiac Arrest in non-traditional areas of care.
Designed for use in public areas, the company’s entire line of Automatic External Defibrillator (AED) products leverages its proprietary, clinically advanced SCOPE technology to optimize the administration of life-saving treatment.
The company’s flagship product line, the HeartSine samaritan® PAD (Public Access Defibrillator)
HeartSine is based Newtown, Pennsylvania and Belfast, Northern Ireland. To learn how a HeartSine AED can save lives, please visit www.heartsine.com/
1. Maron BJ. Sudden death in young athletes. N Engl J Med. Sep 11 2003; 349(11):1064-